|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.3750 AUD | -1.32% |
|
-7.41% | -42.31% |
| 06-26 | Recce Pharmaceuticals to Raise AU$4 million via Share Placement; Shares Down 17% | MT |
| 06-24 | Recce Pharmaceuticals Requests Trading Halt Ahead of Equity Raise | MT |
| Market Cap | 112M 77.86M 68.17M 62.92M 58.08M 110M 7.43B 754M 293M 3.65B 292M 286M 12.66B | P/E 2026 * |
-5.28x | P/E 2027 * | -3.46x |
|---|---|---|---|---|---|
| Enterprise Value | 120M 83.51M 73.11M 67.49M 62.3M 118M 7.97B 809M 315M 3.92B 313M 307M 13.57B | EV / Sales 2026 * |
15.7x | EV / Sales 2027 * | 16.5x |
| Free-Float |
60.56% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | -1.32% | ||
| 1 week | -7.41% | ||
| Current month | -7.41% | ||
| 1 month | -27.18% | ||
| 3 months | -17.58% | ||
| 6 months | -44.85% | ||
| Current year | -42.31% |
| 1 week | 0.37 |  | 0.39 |
| 1 month | 0.37 | | 0.52 |
| Current year | 0.37 | | 0.73 |
| 1 year | 0.31 | | 0.73 |
| 3 years | 0.28 | | 0.78 |
| 5 years | 0.28 | | 1.38 |
| 10 years | 0.13 | | 1.88 |
| Manager | Title | Age | Since |
|---|---|---|---|
James Graham
CEO | Chief Executive Officer | - | 27/08/2020 |
Justin Reynolds
DFI | Director of Finance/CFO | - | - |
Michele Dilizia
CTO | Chief Tech/Sci/R&D Officer | - | 29/09/2020 |
| Director | Title | Age | Since |
|---|---|---|---|
Michele Dilizia
BRD | Director/Board Member | - | 30/09/2012 |
James Graham
BRD | Director/Board Member | - | 30/04/2012 |
| Director/Board Member | - | 31/08/2022 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 02-23 | Expiration | Chief Executive Officer | 2,250,000 | 0.7781% | ||
| 13/10/25 | Expiration | Chief Executive Officer | 745,962 | 0.3217% | ||
| 20/11/24 | Buy | Chief Executive Officer | 3,000,000 | 1.2938% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.32% | -7.41% | +22.95% | -40.48% | 78.92M | |
| -1.60% | +1.37% | +57.31% | +168.94% | 1,102B | |
| -1.44% | +3.71% | +69.64% | +65.40% | 643B | |
| -0.75% | +0.44% | +34.70% | +86.52% | 450B | |
| -1.35% | +0.63% | +30.26% | +26.28% | 336B | |
| -0.86% | +0.99% | +39.36% | +40.85% | 298B | |
| -0.71% | -0.54% | +28.98% | +48.27% | 288B | |
| -1.31% | +2.72% | -26.76% | -39.82% | 222B | |
| -0.03% | +1.62% | +25.62% | +68.30% | 199B | |
| -0.40% | +7.50% | +21.51% | +82.50% | 169B | |
| Average | -0.84% | +1.61% | +30.36% | +50.68% | 370.61B | |
| Weighted average by Cap. | -0.42% | +2.14% | +42.25% | +86.54% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 7.68M 5.32M 4.66M 4.3M 3.97M 7.54M 508M 51.53M 20.06M 250M 19.96M 19.53M 865M | 8.86M 6.14M 5.38M 4.97M 4.58M 8.7M 587M 59.49M 23.16M 288M 23.05M 22.55M 999M |
| Net income | -20.45M -14.18M -12.41M -11.46M -10.58M -20.08M -1.35B -137M -53.43M -665M -53.18M -52.03M -2.3B | -30.9M -21.42M -18.76M -17.31M -15.98M -30.35M -2.05B -207M -80.75M -1B -80.37M -78.64M -3.48B |
| Net Debt | 8.15M 5.65M 4.95M 4.57M 4.22M 8M 540M 54.71M 21.3M 265M 21.2M 20.74M 919M | 33.53M 23.25M 20.35M 18.79M 17.34M 32.93M 2.22B 225M 87.62M 1.09B 87.21M 85.33M 3.78B |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 08/07/26 | A$0.3750 | -1.32% | 167,997 |
| 07/07/26 | A$0.3800 | 0.00% | 150,329 |
| 06/07/26 | A$0.3800 | +1.33% | 190,144 |
| 03/07/26 | A$0.3750 | 0.00% | 222,492 |
| 02/07/26 | A$0.3750 | -1.32% | 680,782 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- RCE Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
